alexa New Developments In Docking And Scoring
ISSN: 2161-0444

Medicinal chemistry
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

3rd International Conference on Medicinal Chemistry & Computer Aided Drug Designing
December 08-10, 2014 DoubleTree by Hilton Hotel San Francisco Airport, USA

Istvan J Enyedy and Mark Mc Gann
ScientificTracks Abstracts: Med Chem
DOI: 10.4172/2161-0444.S1.011
Abstract
Over the last two years, we have set up about 300 internal structures and more than 10, 000 compounds for testing docking and scoring strategies. We used this set for evaluating the new scoring function CHEMGAUSS5 implemented into FRED and HYBRID from OpenEye. The presentation will show the improvements that obtained using the latest scoring function when compared to CHEMGAUSS4, the correlation of a few components of the scoring function with IC50, the impact of using information from solvent mapping to guide docking, and recommended statistical analysis for estimating errors in docking runs.
Biography
Istvan J Enyedy has been involved in new target evaluation, hit finding, and hit-to-lead optimization projects for proteins from several target classes using both ligand and structure-based methods. He is coauthor of more than 30 publications and 11 patents/applications. He received his PhD in 1998 at Catholic University of America, Washington DC, and did postdoctoral training in Dr. Shaomeng Wang?s group at Georgetown University Medical Center, Washington DC. Between 2001 and 2008, he worked at Bayer Pharmaceuticals, West Haven CT and Novartis Institutes for Biomedical Research in Cambridge MA. Since August 2008, he has been working at Biogen Idec, in Cambridge MA.
image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords